Chronic Chlamydia pneumoniae infection and stroke in Cameroon: a case-control study

Area of Science:

• Infectious Diseases
• Neurology
• Public Health

Background:

• Investigating the role of chronic infections in non-communicable diseases.
• Assessing the prevalence of Chlamydia pneumoniae infection in African populations.
• Understanding risk factors for stroke in diverse ethnic groups.

Purpose of the Study:

• To establish the association between chronic Chlamydia pneumoniae infection and stroke incidence.
• To evaluate the diagnostic utility of specific antibody titers (IgA and IgG) against C. pneumoniae in stroke patients.
• To explore potential public health implications for stroke prevention in sub-Saharan Africa.

Main Methods:

• Case-control study design involving 64 stroke patients and 64 matched controls in Yaoundé, Cameroon.
• Serological testing for Chlamydia pneumoniae IgG and IgA antibodies using microimmunofluorescence.
• Statistical analysis to determine the odds ratio (OR) and confidence intervals (CI) for infection markers in relation to stroke.

Main Results:

• A significant association was found between elevated IgA antibody titers against C. pneumoniae and stroke (OR, 4.29; P=0.0002).
• No significant association was observed for IgG antibodies (OR, 1.46; P=0.29).
• The association with IgA antibodies was particularly strong for thrombotic stroke (OR, 21.0; P<0.0001).

Conclusions:

• Chronic Chlamydia pneumoniae infection, identified by IgA serological markers, is significantly associated with stroke in an indigenous African population.
• IgG antibodies did not show a significant association with stroke in this cohort.
• Findings suggest potential for targeted antibiotic strategies in stroke prevention, pending further confirmation.